Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 793-796

  Garg, Ruchi ^a   Wollan, Melissa ^a   Galic, Vijaya ^a   Garcia, Rochelle ^a   Goff, Barbara A ^a   Gray, Heidi J ^a   Swisher, Elizabeth ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

IL6 174 polymorphism; Ovarian; Peritoneal cancers

Indexed keywords

DNA; INTERLEUKIN 6;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALORIMETRY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHI SQUARE TEST; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISHER EXACT TEST; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; DNA; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; WASHINGTON;

EID: 33751395436     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.08.043     Document Type: Article

References (17)

1. Syed V., Ulinski G., Mok S.C., and Ho S.M. Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J. Natl. Cancer Inst. 94 8 (2002) 617-629
2. Bowcock A.M., Kidd J.R., Lathrop G.M., Daneshvar L., May L.T., Ray A., et al. The human "interferon-beta/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 1 (1988) 8-16
3. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102 (1998) 1369-1376
4. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275 24 (2000) 18138-18144
5. DeMichele A., Martin A.M., Mick R., Gor P., Wray L., Klein-Cabral M., et al. Interleukin-6 - 174G → C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 63 (2003) 8051-8056
6. Hefler L.A., Grimm C., Ackermann S., Malur S., Radjabi-Rahat A.R., Leodolter S., et al. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res. 63 (2003) 3066-3068
7. Plante M., Rubin S.C., Wong G.Y., Federici M.G., Finstad C.L., and Gastl G.A. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 73 7 (1994) 1882-1888
8. Scambia G., Testa U., Panici P.B., et al. Interleukin-6 and serum levels in patients with gynecological tumors. Int. J. Cancer 57 (1994) 318-323
9. Scambia G., Testa U., Benedetti P.P., Foti E., Martucci R., Gassucci A., et al. Prognostic significance of IL-6 serum levels in patients with ovarian cancer. Br. J. Cancer 71 2 (1995) 354-356
10. Tempfer C., Zeisler H., Sliutz G., Haeusler G., Hanzal E., and Kainz C. Serum evaluation of interleukin 6 in ovarian cancer patients. Gynecol. Oncol. 67 (1997) 27-30
11. Berek J.S., Chung C., Kaldi K., Watson J.M., Knox R.M., and Martionez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am. J. Obstet. Gynecol. 164 (1991) 1038-1043
12. Nilsson M.B., Langley R.R., and Fidler IJ. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res. 65 23 (2005) 10794-10800
13. Watson J.M., Berek J.S., and Martinez-Maza O. Growth inhibition of ovarian-cancer cells induced by antisense IL-6 oligonucleotides. Gynecol. Oncol. 49 (1993) 8-15
14. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., and Miller GJ. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 22 (2001) 2243-2252
15. Belluco C., Olivieri F., Bonafe M., Giovagnetti S., Mammano E., Scalerta R., et al. - 174G > C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin. Cancer Res. 9 (2003) 2173-2176
16. Cavet J., Dickinson A.M., Norden J., Taylor P.R., Jackson G.H., and Middleton P.G. Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 98 (2001) 1594-1600
17. Hulkkonen J., Pertovaara M., Antonen J., Pasternack A., and Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40 (2001) 656-661